Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|June 9, 2016
Clinical responses with T lymphocytes targeting malignancy-associated κ light chainsCarlos A Ramos, Barbara Savoldo, Vicky Torrano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 14, 2013
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastomaMeenakshi Hegde, Amanda Corder, Kevin K H Chow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2013
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteinsCatherine M Bollard, Stephen Gottschalk, Vicky Torrano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich SyndromeAlexander Ngwube, I Celine Hanson, Jordan Orange, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activityAlana A Kennedy-Nasser, Stephanie Ku, Paul Castillo-Caro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2018
In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's LymphomasCarlos A Ramos, Rayne Rouce, Catherine S Robertson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2018
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin LymphomaCatherine M Bollard, Tamara Tripic, Conrad Russell Cruz, et al.
British Journal of Haematology|April 3, 2015
A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group studyTerzah M Horton, Richard A Drachtman, Lu Chen, et al.
Blood|April 23, 2014
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgeneXiaoou Zhou, Antonio Di Stasi, Siok-Keen Tey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2017
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell TransplantationIfigeneia Tzannou, Anastasia Papadopoulou, Swati Naik, et al.
Pageof 7